Curbstone Financial Management Corp Purchases 750 Shares of CVS Health Co. (NYSE:CVS)

Curbstone Financial Management Corp boosted its position in CVS Health Co. (NYSE:CVS) by 2.8% during the second quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 27,136 shares of the pharmacy operator’s stock after buying an additional 750 shares during the quarter. Curbstone Financial Management Corp’s holdings in CVS Health were worth $1,876,000 as of its most recent filing with the SEC.

A number of other large investors have also recently bought and sold shares of the company. Live Oak Investment Partners acquired a new position in CVS Health during the fourth quarter worth $25,000. Freedom Wealth Alliance LLC bought a new position in shares of CVS Health in the 4th quarter valued at about $40,000. True Wealth Design LLC bought a new stake in CVS Health during the fourth quarter worth about $48,000. 25 LLC acquired a new position in CVS Health during the first quarter valued at approximately $39,000. Finally, General Partner Inc. bought a new position in CVS Health in the first quarter valued at approximately $47,000. Institutional investors and hedge funds own 75.99% of the company’s stock.

Insider Activity at CVS Health

In other CVS Health news, SVP James David Clark sold 25,759 shares of the business’s stock in a transaction on Thursday, August 3rd. The stock was sold at an average price of $74.92, for a total value of $1,929,864.28. Following the sale, the senior vice president now directly owns 4,698 shares in the company, valued at $351,974.16. The sale was disclosed in a filing with the SEC, which is accessible through this link. 0.25% of the stock is owned by company insiders.

CVS Health Stock Up 0.1 %

Shares of CVS Health stock traded up $0.08 during trading on Thursday, reaching $70.32. 1,267,096 shares of the company traded hands, compared to its average volume of 9,088,836. The company has a debt-to-equity ratio of 0.84, a current ratio of 0.86 and a quick ratio of 0.64. The firm has a market capitalization of $90.32 billion, a PE ratio of 30.81, a P/E/G ratio of 1.24 and a beta of 0.63. The company has a 50 day moving average price of $70.77 and a 200-day moving average price of $72.05. CVS Health Co. has a 1-year low of $64.62 and a 1-year high of $104.83.

CVS Health (NYSE:CVS) last announced its quarterly earnings data on Wednesday, August 2nd. The pharmacy operator reported $2.21 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.12 by $0.09. The firm had revenue of $88.92 billion during the quarter, compared to the consensus estimate of $86.41 billion. CVS Health had a return on equity of 15.43% and a net margin of 0.86%. The business’s revenue for the quarter was up 10.3% on a year-over-year basis. During the same quarter in the prior year, the company earned $2.40 EPS. As a group, equities research analysts expect that CVS Health Co. will post 8.61 earnings per share for the current fiscal year.

CVS Health Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Tuesday, August 1st. Investors of record on Friday, July 21st were issued a $0.605 dividend. The ex-dividend date of this dividend was Thursday, July 20th. This represents a $2.42 dividend on an annualized basis and a dividend yield of 3.44%. CVS Health’s dividend payout ratio (DPR) is presently 106.14%.

Analysts Set New Price Targets

Several research firms recently weighed in on CVS. Wolfe Research raised shares of CVS Health from a “peer perform” rating to an “outperform” rating and set a $80.00 target price for the company in a research note on Tuesday. Barclays dropped their target price on shares of CVS Health from $89.00 to $86.00 and set an “overweight” rating on the stock in a report on Thursday, August 3rd. Mizuho reduced their price target on CVS Health from $120.00 to $88.00 in a report on Tuesday, July 11th. Royal Bank of Canada restated an “outperform” rating and issued a $91.00 price objective on shares of CVS Health in a research note on Friday, August 18th. Finally, JPMorgan Chase & Co. reduced their target price on CVS Health from $114.00 to $106.00 in a research note on Friday, July 7th. Three research analysts have rated the stock with a hold rating and fourteen have given a buy rating to the company. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average price target of $96.00.

CVS Health Company Profile

CVS Health Corporation provides health services in the United States. It operates through Health Care Benefits, Pharmacy Services, and Retail/LTC segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services. It serves employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governmental units, government-sponsored plans, labor groups, and expatriates.